510 related articles for article (PubMed ID: 24484176)
1. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer.
Hilska M; Roberts PJ; Collan YU; Laine VJ; Kössi J; Hirsimäki P; Rahkonen O; Laato M
Int J Cancer; 2007 Aug; 121(4):714-23. PubMed ID: 17455256
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour.
Siqueira AS; Carvalho MR; Monteiro AC; Freitas VM; Jaeger RG; Pinheiro JJ
Histopathology; 2010 Jul; 57(1):128-37. PubMed ID: 20653784
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors.
Kumamoto H; Ooya K
J Oral Pathol Med; 2006 Jul; 35(6):345-51. PubMed ID: 16762015
[TBL] [Abstract][Full Text] [Related]
5. Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2.
Brun JL; Cortez A; Commo F; Uzan S; Rouzier R; Daraï E
Int J Oncol; 2008 Dec; 33(6):1239-46. PubMed ID: 19020757
[TBL] [Abstract][Full Text] [Related]
6. MMP-7 and TIMP-1, new targets in predicting poor wound healing in apical periodontitis.
Letra A; Ghaneh G; Zhao M; Ray H; Francisconi CF; Garlet GP; Silva RM
J Endod; 2013 Sep; 39(9):1141-6. PubMed ID: 23953287
[TBL] [Abstract][Full Text] [Related]
7. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
[TBL] [Abstract][Full Text] [Related]
8. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy.
Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS
Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of extracellular matrix metalloproteinase inducer is associated with matrix metalloproteinase-1 and -2 in gingival tissues from patients with periodontitis.
Dong W; Xiang J; Li C; Cao Z; Huang Z
J Periodontal Res; 2009 Feb; 44(1):125-32. PubMed ID: 19515022
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids of patients with temporomandibular joint osteoarthritis.
Kanyama M; Kuboki T; Kojima S; Fujisawa T; Hattori T; Takigawa M; Yamashita A
J Orofac Pain; 2000; 14(1):20-30. PubMed ID: 11203734
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and their tissue inhibitors in the lesions of cardiac and pulmonary sarcoidosis: an immunohistochemical study.
González AA; Segura AM; Horiba K; Qian S; Yu ZX; Stetler-Stevenson W; Willerson JT; McAllister HA; Ferrans VJ
Hum Pathol; 2002 Dec; 33(12):1158-64. PubMed ID: 12514782
[TBL] [Abstract][Full Text] [Related]
12. Regulation of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and extracellular metalloproteinase inducer by interleukin-17 in human periodontal ligament fibroblasts.
Wu Y; Zhu L; Wei H; Peng B
J Endod; 2013 Jan; 39(1):62-7. PubMed ID: 23228259
[TBL] [Abstract][Full Text] [Related]
13. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls.
Masumoto K; de Rooij JD; Suita S; Rottier R; Tibboel D; de Krijger RR
Histopathology; 2006 Apr; 48(5):588-95. PubMed ID: 16623785
[TBL] [Abstract][Full Text] [Related]
14. Matrix-metalloproteinases in Hodgkin lymphoma.
Thorns C; Bernd HW; Hatton D; Merz H; Feller AC; Lange K
Anticancer Res; 2003; 23(2B):1555-8. PubMed ID: 12820423
[TBL] [Abstract][Full Text] [Related]
15. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
[TBL] [Abstract][Full Text] [Related]
16. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
Cury PR; de Araújo VC; Canavez F; Furuse C; Leite KR; de Araújo NS
Arch Oral Biol; 2007 Jun; 52(6):585-90. PubMed ID: 17181997
[TBL] [Abstract][Full Text] [Related]
17. Temporospatial distribution of matrix metalloproteinase and tissue inhibitors of matrix metalloproteinases during murine secondary palate morphogenesis.
Morris-Wiman J; Burch H; Basco E
Anat Embryol (Berl); 2000 Aug; 202(2):129-41. PubMed ID: 10985432
[TBL] [Abstract][Full Text] [Related]
18. Secretion of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries.
Riley SC; Gibson AH; Leask R; Mauchline DJ; Pedersen HG; Watson ED
Reproduction; 2001 Apr; 121(4):553-60. PubMed ID: 11277874
[TBL] [Abstract][Full Text] [Related]
19. Involvement of matrix metalloproteinases 2 and 9, tissue inhibitor of metalloproteinases and apoptosis in tissue remodelling in the sheep placenta.
Riley SC; Webb CJ; Leask R; McCaig FM; Howe DC
J Reprod Fertil; 2000 Jan; 118(1):19-27. PubMed ID: 10793622
[TBL] [Abstract][Full Text] [Related]
20. Variations on brain microglial gene expression of MMPs, RECK, and TIMPs in inflammatory and non-inflammatory diseases in dogs.
Stein VM; Puff C; Genini S; Contioso VB; Baumgärtner W; Tipold A
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):17-26. PubMed ID: 21802747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]